Dysport Therapeutic (abobotulinumtoxina)

pCPA File Number: 21046

Negotiation Status:

Concluded with an LOI

Indication(s):

Upper Limb Spasticity

Sponsor/Manufacturer:

Ipsen Biopharmaceuticals Canada, Inc.

CDA-AMC Project Number:

SR0517-000

pCPA Engagement Letter Issued:

2018-05-04

Negotiation Process Concluded:

2018-07-17